STAT signaling in head and neck cancer

The upper aerodigestive tract is predisposed to the formation of multiple primary tumors due to field cancerization. TGF-α/EGFR autocrine signaling appears to play an important role in squamous cell carcinoma of the head and neck (SCCHN) and upregulation of TGF-α and EGFR is an early event in SCCHN carcinogenesis. STAT proteins, including Stat3, are activated by TGF-α and EGFR and strategies that downmodulate TGF-α or EGFR inhibit SCCHN cell proliferation and abrogate Stat3 activation. Targeting Stat3 leads to SCCHN growth inhibition, increases apoptosis and a downmodulation of Bcl-xL expression in head and neck tumors. These studies support the role of Stat3 as an oncogene, which is activated early in SCCHN carcinogenesis, and efforts to understand EGFR-mediated Stat3 signaling could facilitate novel strategies that will interfere with this growth promoting pathway.

[1]  D. Nathans,et al.  In vitro activation of Stat3 by epidermal growth factor receptor kinase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Roy Garcia,et al.  STATs in oncogenesis , 2000, Oncogene.

[3]  J. Ihle.  STATs: Signal Transducers and Activators of Transcription , 1996, Cell.

[4]  R. Jove,et al.  Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. , 1995, Science.

[5]  K. Kinzler,et al.  The multistep nature of cancer. , 1993, Trends in genetics : TIG.

[6]  J. Siegfried,et al.  Expression of mRNA for gastrin-releasing peptide receptor by human bronchial epithelial cells. Association with prolonged tobacco exposure and responsiveness to bombesin-like peptides. , 1997, American journal of respiratory and critical care medicine.

[7]  Dushanka V. Kleiman.  Cancers of the oral cavity and pharynx : a statistics review monograph, 1973-1987 , 1991 .

[8]  P. Heinrich,et al.  Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level , 1993, Molecular and cellular biology.

[9]  J. Darnell,et al.  Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. , 1994, Science.

[10]  R. Jove,et al.  Activation of STAT transcription factors in oncogenic tyrosine kinase signaling. , 1998, Journal of biomedical science.

[11]  T. Hirano,et al.  A central role for Stat3 in IL‐6‐induced regulation of growth and differentiation in M1 leukemia cells. , 1996, The EMBO journal.

[12]  W. Panje,et al.  Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines , 1989, Head & neck.

[13]  C. Watson,et al.  Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts. , 1995, British Journal of Cancer.

[14]  J. Siegfried,et al.  Effects of bombesin and gastrin‐releasing peptide on human bronchial epithelial cells from a series of donors: Individual variation and modulation by bombesin analogs , 1993, The Anatomical record.

[15]  P. Van cauwenberge,et al.  Multiple Primary Malignant Tumors in Patients With Head and Neck Cancer , 1998, The Laryngoscope.

[16]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[17]  R. Bradshaw,et al.  Polypeptide growth factors. , 1984, Annual review of biochemistry.

[18]  J. Darnell,et al.  A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. , 1993, Science.

[19]  M. Feldmann,et al.  Production of TGF-alpha and TGF-beta by cultured keratinocytes, skin and oral squamous cell carcinomas--potential autocrine regulation of normal and malignant epithelial cell proliferation. , 1989, British Journal of Cancer.

[20]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[21]  G. Snow,et al.  Second respiratory and upper digestive tract cancer following oral squamous cell carcinoma. , 1994, European journal of cancer. Part B, Oral oncology.

[22]  S. Castigliano.  Influence of continued smoking on the incidence of second primary cancers involving mouth, pharynx, and larynx. , 1968, Journal of the American Dental Association.

[23]  J. Grandis,et al.  Retinoic acid normalizes the increased gene transcription rate of TGF–α and EGFR in head and neck cancer cell lines , 1996, Nature Medicine.

[24]  R. Todd,et al.  TGF-α and EGF-receptor mRNAs in human oral cancer , 1989 .

[25]  J. Turkson,et al.  Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. , 1999, Immunity.

[26]  R. Day,et al.  Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival , 1998 .

[27]  E. Tahara,et al.  EGF and TGF‐α, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors , 1990 .

[28]  J. Grandis,et al.  Epidermal Growth Factor Receptor–Mediated Stat3 Signaling Blocks Apoptosis in Head and Neck Cancer , 2000, The Laryngoscope.

[29]  D. Tweardy,et al.  Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells , 1997, Oncogene.

[30]  Y. Matsuzawa,et al.  STAT3 mediates the survival signal in oncogenic ras‐transfected intestinal epithelial cells , 1998, International journal of cancer.

[31]  J. Darnell.  STATs and gene regulation. , 1997, Science.

[32]  B. Gusterson,et al.  Over‐expression of the EGF receptor is a hallmark of squamous cell carcinomas , 1986, The Journal of pathology.

[33]  J. Siegfried,et al.  Expression of mRNA for three bombesin receptor subtypes in human bronchial epithelial cells. , 1994, American journal of respiratory cell and molecular biology.

[34]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[35]  Simon C Watkins,et al.  Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  K. Asano,et al.  Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. , 1989, British Journal of Cancer.

[37]  M. Willingham,et al.  EGF-R antisense RNA blocks expression of the epidermal growth factor receptor and suppresses the transforming phenotype of a human carcinoma cell line. , 1992, The Journal of biological chemistry.

[38]  J. Grandis,et al.  Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. , 1993, Cancer research.

[39]  J. Grandis,et al.  Downmodulation of TGF‐α protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells , 1998, Journal of cellular biochemistry.

[40]  Simon C Watkins,et al.  Interleukin-6 production in hemorrhagic shock is accompanied by neutrophil recruitment and lung injury. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[41]  G. Carpenter.  Receptor tyrosine kinase substrates: src homology domains and signal transduction , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  J. Darnell,et al.  Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[43]  G. Adams,et al.  Survival Statistics for Multiple Primaries in Head and Neck Cancer , 1990, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[44]  W. Hong,et al.  Overview of combined modality therapies for head and neck cancer. , 1993, Journal of the National Cancer Institute.

[45]  S. Bustin,et al.  Transforming growth factor alpha. , 1995, Cell biology international.

[46]  C. Scully,et al.  Recent advances in epidemiology of head and neck cancer , 1992, Current opinion in oncology.

[47]  N. Perrimon,et al.  Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. , 1995, The EMBO journal.

[48]  W. Hong,et al.  Chemotherapy in head and neck cancer. , 1983, The New England journal of medicine.

[49]  Xin-Yuan Fu,et al.  Cell Growth Arrest and Induction of Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Mediated by STAT1 , 1996, Science.

[50]  T. Matsumura,et al.  Quantitative Assay of Epidermal Growth Factor Receptor in Human Squamous Cell Carcinomas of the Oral Region by an Avidin‐Biotin Method , 1991, Japanese journal of cancer research : Gann.

[51]  D. Tweardy,et al.  Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[52]  Alan Wells,et al.  STAT Activation by Epidermal Growth Factor (EGF) and Amphiregulin , 1996, The Journal of Biological Chemistry.

[53]  P. Coffer,et al.  EGF receptor deletions define a region specifically mediating STAT transcription factor activation. , 1995, Biochemical and biophysical research communications.

[54]  A. Bridges,et al.  A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. , 1994, Science.

[55]  D. Levy,et al.  Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor , 1996, Molecular and cellular biology.

[56]  J. Grandis,et al.  Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro. , 1998, The Journal of clinical investigation.

[57]  M. Hanley,et al.  Malignant transformation by G protein-coupled hormone receptors , 1994, Molecular and Cellular Endocrinology.

[58]  S. Becker,et al.  Three-dimensional structure of the Stat3β homodimer bound to DNA , 1998, Nature.

[59]  M. Herlyn,et al.  Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. , 1989, The EMBO journal.

[60]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.